Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, April 7, 2022
[ Thu, Apr 07th 2022
] - WOPRAI
[ Thu, Apr 07th 2022
] - WOPRAI
[ Thu, Apr 07th 2022
] - WOPRAI
[ Thu, Apr 07th 2022
] - WOPRAI
[ Thu, Apr 07th 2022
] - WOPRAI
[ Thu, Apr 07th 2022
] - WOPRAI
[ Thu, Apr 07th 2022
] - WOPRAI
[ Thu, Apr 07th 2022
] - WOPRAI
[ Thu, Apr 07th 2022
] - WOPRAI
[ Thu, Apr 07th 2022
] - WOPRAI
[ Thu, Apr 07th 2022
] - WOPRAI
[ Thu, Apr 07th 2022
] - WOPRAI
[ Thu, Apr 07th 2022
] - WOPRAI
[ Thu, Apr 07th 2022
] - WOPRAI
[ Thu, Apr 07th 2022
] - WOPRAI
[ Thu, Apr 07th 2022
] - WOPRAI
Wed, April 6, 2022
[ Wed, Apr 06th 2022
] - WOPRAI
[ Wed, Apr 06th 2022
] - WOPRAI
[ Wed, Apr 06th 2022
] - WOPRAI
[ Wed, Apr 06th 2022
] - WOPRAI
[ Wed, Apr 06th 2022
] - WOPRAI
[ Wed, Apr 06th 2022
] - WOPRAI
[ Wed, Apr 06th 2022
] - WOPRAI
[ Wed, Apr 06th 2022
] - WOPRAI
[ Wed, Apr 06th 2022
] - WOPRAI
[ Wed, Apr 06th 2022
] - WOPRAI
[ Wed, Apr 06th 2022
] - WOPRAI
[ Wed, Apr 06th 2022
] - WOPRAI
[ Wed, Apr 06th 2022
] - WOPRAI
Michael Rose Upgraded (CFR) to Buy and Held Target at $160 on, Apr 6th, 2022
Michael Rose of Raymond James, Upgraded "Cullen/Frost Bankers, Inc." (CFR) to Buy and Held Target at $160 on, Apr 6th, 2022.
Michael has made no other calls on CFR in the last 4 months.
There is 1 other peer that has a rating on CFR. Out of the 1 peers that are also analyzing CFR, 0 agree with Michael's Rating of Hold.
This is the rating of the analyst that currently disagrees with Michael
- Ken Zerbe of "Morgan Stanley" Maintained at Sell with Increased Target to $108 on, Monday, December 6th, 2021
